Helminthiasis refers to infections caused by parasitic worms, including nematodes (roundworms), trematodes (flukes), and cestodes (tapeworms). These parasitic infections are prevalent in various parts of the world, particularly in areas with poor sanitation and limited access to clean water. Common helminth infections include soil-transmitted helminths like Ascaris lumbricoides, Trichuris trichiura, and hookworms, as well as schistosomiasis and intestinal tapeworm infections. Clinical symptoms of helminthiasis vary depending on the type of worm and the severity of the infection. Common manifestations include abdominal pain, diarrhea, weight loss, anemia, and nutritional deficiencies. Chronic and heavy infestations can lead to long-term health consequences, particularly in children. Preventive measures for helminthiasis involve improved sanitation, access to clean water, and health education on proper hygiene practices. Mass drug administration programs with anthelminthic medications target high-risk populations in endemic areas. Research efforts focus on developing new drugs, understanding the immunology of helminth infections, and exploring innovative strategies for controlling the spread of these parasitic worms.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain